ACT-03 Clinical outcome and radiological findings of patients with recurrent glioblastomas treated by bevacizumab

Object: Seven years have passed since the approval of bevacizumab (BEV) in Japan. We retrospectively reviewed the clinical outcome and radiological findings of patients with recurrent glioblastomas (GB) treated by BEV. Method: We reviewed 116 patients, including 27 cases of newly diagnosed GB and 89...

Descripción completa

Detalles Bibliográficos
Autores principales: Handa, Hajime, Shibahara, Ichiyo, Hide, Takuichiro, Kumabe, Toshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699037/
http://dx.doi.org/10.1093/noajnl/vdaa143.033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699037/
http://dx.doi.org/10.1093/noajnl/vdaa143.033

Ejemplares similares